More Groups Sue EPA Over Roundup Re-Approval

Amid continuing concerns about the side effects of Roundup exposure, a growing number of environmental groups and consumer watchdogs have filed lawsuits against over the federal government’s controversial decision to re-approve use of the weedkiller and other products with the active ingredient glyphosate.

The Rural Coalition, Farmworker Association of Florida, Beyond Pesticides, the Center for Food Safety (CFS), and the Organizacion En California De Linderes Campesinas all filed a joint petition for review (PDF) in the U.S. Court of Appeals for the Ninth Circuit on March 20, calling for the judiciary to overturn the U.S. Environmental Protection Agency (EPA) re-approval of glyphosate earlier this year.

The lawsuit was filed the same day as a nearly identical complaint by the National Resources Defense Council and Pesticide Action Network North America. Both petitions say the EPA has ignored evidence by scientists and medical experts about the adverse health effects and environmental impact of glyphosate, in order to appease corporate interests.


Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More About this Lawsuit See If You Qualify For Compensation

“EPA’s half-completed, biased, and unlawful approval sacrifices the health of farmworkers and endangered species at the altar of Monsanto profits,” George Kimbrell, Legal Director for CFS and counsel for the coalition, said in a press release. “The reckoning for Roundup is coming.”

In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) announced that glyphosate is likely a cancer-causing agent. In particular, the IARC report linked the side effects of Roundup and other glyphosate-based herbicides with an increased risk of non-Hodgkin’s lymphoma.

Despite growing evidence about the dangers associated with exposure to Roundup, the EPA has continued to defend glyphosate and Monsanto’s Roundup weed killer products against the cancer claims, as well as against claims that the herbicide causes devastating damage to key pollinators like bees and butterflies.

In April 2019, the EPA issued a proposed interim registration review decision saying the agency does not believe glyphosate can cause cancer. It finalized that decision in January.

Bayer and its Monsanto subsidiary face tens of thousands of Roundup lawsuits filed nationwide, each involving allegations that users developed non-Hodgkins lymphoma or other cancers.

Although Bayer and its Monsanto subsidiary have continued to defend the safety of glyphosate, the companies have faced massive verdicts in several early trials that have gone forward in the United States, over failure to warn about the risks associated with Roundup exposure, including massive punitive damage awards designed to punish the manufacturer for withholding safety information from consumers and government regulators.

Over the next year, unless the manufacturer is able to reach Roundup settlements for the glyphosate cancer claims, a number of additional cases are expected to go to trial nationwide.


  • JeromeApril 1, 2020 at 9:42 pm

    10 year history of multiple myeloma, and 20 year use of Roundup.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.